Heron Therapeuti (HRTX) Stock Analysis

Heron Therapeuti (HRTX) is a publicly traded company in the HEALTHCARE sector. It trades at $0.45, carries a market capitalization of $156.57M. This page summarizes the public market data, fundamentals, and frequently asked questions for HRTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.45
• Market Cap: $156.57M
• EPS: $-0.18
• 52-Week High: $2.30
• 52-Week Low: $0.74

Market Sentiment

Heron Therapeuti currently has a Neutral sentiment score of -0.13.

About Heron Therapeuti

Heron Therapeutics, Inc. (HRTX), based in San Diego, California, is a biotechnology company dedicated to developing innovative therapies that address substantial unmet medical needs in pain management and antiemetic care. The firm specializes in the research and commercialization of novel pharmaceutical products aimed at enhancing the quality of life for patients undergoing surgical procedures and cancer treatments. With a robust pipeline and a strategic focus on high-demand therapeutic areas...

GNG Research Analysis

GNG Research scores Heron Therapeuti (HRTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HRTX.

Frequently Asked Questions

Does HRTX pay dividends?

Heron Therapeuti (HRTX) does not currently pay a regular dividend.

What is HRTX's market cap?

Heron Therapeuti (HRTX) has a market capitalization of $156.57M with a current stock price of $0.45.